Aureka Biotechnologies Funding: $100M Raised, Series A
Aureka Biotechnologies is based in Laguna Hills, California. It has raised $100M in total funding. Latest round: Series A.
Aureka Biotechnologies funding overview
Aureka Biotechnologies is based in Laguna Hills, California. Aureka Biotechnologies has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Aureka Biotechnologies runs through 2025; nothing later has been disclosed. Investors on record include Sequoia Capital China, Matrix Partners China, Boyuan Capital, Wuyuan Capital, Qiming Venture Partners, New Leaf Capital. 6 distinct backers are named across the disclosed rounds.
Aureka Biotechnologies at a glance
Total raised
$100M
Latest round
Series A
Latest round date
December 2025
Headquarters
Laguna Hills, California
Notable investors
Sequoia Capital China, Matrix Partners China, Boyuan Capital, Wuyuan Capital, Qiming Venture Partners, New Leaf Capital
Frequently asked about Aureka Biotechnologies funding
How much has Aureka Biotechnologies raised?
Aureka Biotechnologies has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Aureka Biotechnologies?
Sequoia Capital China, Matrix Partners China, Boyuan Capital, Wuyuan Capital, Qiming Venture Partners, New Leaf Capital are named among the investors backing Aureka Biotechnologies.
What was the latest Aureka Biotechnologies funding round?
The most recent disclosed round is a Series A, announced in December 2025.
Where is Aureka Biotechnologies based?
Aureka Biotechnologies is based in Laguna Hills, California.
When did Aureka Biotechnologies last raise?
The last disclosed Aureka Biotechnologies round closed in December 2025 at Series A.
Totals shown for Aureka Biotechnologies aggregate every disclosed round on file. To see how that compares, browse the companies in Laguna Hills and the investors behind them below.
